Aurora Drug Discovery Description

Aurora uses quantum mechanics, thermodynamics and an advanced continuous-water model for solvation effects in order to calculate ligand binding affinities. This approach is significantly different from the binding affinity predictions that are often based on scoring functions. Aurora algorithms are able to produce more precise and reliable binding free energies values by including the entropy as well as the aqueous electrostatic contribution directly into the calculations. The binding free energy is the measure of interaction between a ligand and a protein. The free energy (F), which is a thermodynamic quantity directly related to the experimentally measurable value for inhibition constant (IC50), and depends on the statistical properties of interacting molecules as well as electrostatic, quantum, and aqueous solver forces, is a thermodynamic quantity. Two major contributors to F's non-additivity are 1) the electrostatic and the solvation energy, and 2) the entropy.

Integrations

No Integrations at this time

Reviews

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Company Details

Company:
Aurora Fine Chemicals
Year Founded:
1990
Headquarters:
United States
Website:
aurorafinechemicals.com/drug-discovery-software.html

Media

Aurora Drug Discovery Screenshot 1
Recommended Products
Secure your business by securing your people. Icon
Secure your business by securing your people.

Over 100,000 businesses trust 1Password

Take the guesswork out of password management, shadow IT, infrastructure, and secret sharing so you can keep your people safe and your business moving.

Product Details

Platforms
SaaS
Customer Support
Phone Support
Online

Aurora Drug Discovery Features and Options